다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Gyre Therapeutics Inc (GYRE)
Gyre Therapeutics Inc (GYRE) 뉴스

GYRE

Gyre Therapeutics (GYRE)

Gyre Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:GYRE

1

일자	시간	출처	헤드라인	심볼	기업
2024/05/31	05:06	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:GYRE	Gyre Therapeutics Inc
2024/05/31	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GYRE	Gyre Therapeutics Inc
2024/05/31	05:05	GlobeNewswire Inc.	Gyre Pharmaceuticals Receives IND Approval from China’s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial Hypertension	NASDAQ:GYRE	Gyre Therapeutics Inc
2024/05/31	05:02	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:GYRE	Gyre Therapeutics Inc
2024/05/29	05:05	GlobeNewswire Inc.	Gyre Therapeutics Announces Expected Addition to the Russell 2000® and Russell 3000® Indexes	NASDAQ:GYRE	Gyre Therapeutics Inc
2024/05/14	05:07	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:GYRE	Gyre Therapeutics Inc
2024/05/10	05:10	GlobeNewswire Inc.	Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:GYRE	Gyre Therapeutics Inc
2024/05/10	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GYRE	Gyre Therapeutics Inc
2024/05/08	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GYRE	Gyre Therapeutics Inc
2024/03/26	19:00	GlobeNewswire Inc.	Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update	NASDAQ:GYRE	Gyre Therapeutics Inc
2024/03/21	20:00	GlobeNewswire Inc.	Gyre Therapeutics Expands Board of Directors with Appointment of Rodney L. Nussbaum	NASDAQ:GYRE	Gyre Therapeutics Inc
2023/12/15	23:04	PR Newswire (US)	Totus Medicines Announces Appointment of Nassim Usman, Ph.D., as President & CEO and the Closing of a $66M Series B Funding	NASDAQ:GYRE	Gyre Therapeutics Inc
2023/11/13	21:00	GlobeNewswire Inc.	Gyre Therapeutics Presents Poster at the American Association for the Study of Liver Diseases (AASLD) Annual Liver Meeting	NASDAQ:GYRE	Gyre Therapeutics Inc
2023/11/03	06:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GYRE	Gyre Therapeutics Inc
2023/11/02	06:18	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:GYRE	Gyre Therapeutics Inc
2023/11/02	05:58	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:GYRE	Gyre Therapeutics Inc

검색 관련기사 보기:NASDAQ:GYRE

1

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관